Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 15, 2024
Investigating the effect of LncRNA DLGAP1-AS2 suppression on chemosensitivity of gastric cancer to chemotherapySeyedeh Samin Azadi, Reza Safaralizadeh, Mohammad Amini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 5, 2021
PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokinesParisa Lotfinejad, Tohid Kazemi, Sahar Safaei, et al.
Neurotoxicology|March 19, 2018
Maternal exposure to silver nanoparticles are associated with behavioral abnormalities in adulthood: Role of mitochondria and innate immunity in developmental toxicityShayan Amiri, Aliakbar Yousefi-Ahmadipour, Mir-Jamal Hosseini, et al.
Physical Review Letters|December 23, 2024
Emergence of Exotic Spin Texture in Supramolecular Metal Complexes on a 2D SuperconductorViliam Vaňo, Stefano Reale, Orlando J Silveira, et al.
Iranian Journal of Basic Medical Sciences|June 5, 2023
Hydrogel nanocomposite based on alginate/zeolite for burn wound healing:Hadi Samadian, Reza Vahidi, Majid Salehi, et al.
Human Brain Mapping|September 15, 2005
Age-related morphology trends of cortical sulciPeter Kochunov, Jean-François Mangin, Thomas Coyle, et al.
American Journal of Clinical Oncology|December 15, 2015
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244Heinrich Elinzano, Michael Glantz, Maciej Mrugala, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?Lizza E L Hendriks, -Anita J W M Brouns, Mohammad Amini, et al.
Blood Advances|March 6, 2024
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet componentsAllison P Wheeler, Edward L Snyder, Majed Refaai, et al.
Transfusion|June 24, 2022
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet componentsEdward L Snyder, Allison P Wheeler, Majed Refaai, et al.
Pageof 17